Purchase Restrictions: Shares of Capital Group Central Corporate Bond Fund (“fund”) are not offered to the public. Investments in the fund may be made only by certain institutional investors, including investment companies and certain other investment vehicles and accounts managed by the fund’s investment adviser and its affiliates. Shares of the fund are restricted securities and cannot be transferred or resold without registration under the Securities Act of 1933, as amended (“1933 Act”), or an available exemption from registration under the 1933 Act.
BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
765 Total Holdings:
As of 12/31/25
All Holdings:
1 -
15 of
765
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 10,985,975 | $1,098,707,391.00 | 9.94% |
| U.S. Treasury 4.00% 11/15/2035 | Fixed Income | 360,380,000 | $355,481,066.00 | 3.22% |
| TREASURY NOTE 3.5% 12-31-30 | Fixed Income | 285,875,400 | $284,568,864.00 | 2.58% |
| U.S. Treasury 4.75% 8/15/2055 | Fixed Income | 250,519,100 | $246,838,173.00 | 2.23% |
| U.S. Treasury 4.625% 11/15/2045 | Fixed Income | 88,721,000 | $86,807,962.00 | 0.79% |
| Morgan Stanley 4.356% 10/22/2031 (USD-SOFR + 1.074% on 10/22/2030) | Fixed Income | 85,003,000 | $84,742,126.00 | 0.77% |
| Bristol-Myers Squibb Co. 5.20% 2/22/2034 | Fixed Income | 76,118,000 | $79,154,651.00 | 0.72% |
| Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 77,669,000 | $79,484,668.00 | 0.72% |
| U.S. Treasury 3.50% 12/15/2028 | Fixed Income | 74,853,600 | $74,768,806.00 | 0.68% |
| New Economy Assets Phase 1 Issuer, LLC, Series 2021-1, Class A1, 1.91% 10/20/2061 | Fixed Income | 85,298,000 | $71,459,423.00 | 0.65% |
| Takeda U.S. Financing, Inc. 5.20% 7/7/2035 | Fixed Income | 69,251,000 | $70,567,323.00 | 0.64% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 66,997,000 | $68,874,390.00 | 0.62% |
| Oracle Corp. 5.50% 8/3/2035 | Fixed Income | 64,456,000 | $63,193,629.00 | 0.57% |
| Morgan Stanley 4.892% 10/22/2036 (USD-SOFR + 1.314% on 10/22/2035) | Fixed Income | 62,234,000 | $61,706,816.00 | 0.56% |
| Pfizer Investment Enterprises Pte., Ltd. 5.30% 5/19/2053 | Fixed Income | 65,138,000 | $61,720,861.00 | 0.56% |
All Holdings:
1 -
15 of
765